3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
11
Carcinoma, Intraductal, Noninfiltrating
3
Infertility
2
Breast Carcinoma In Situ
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Polycystic Ovary Syndrome
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Hereditary Sensory and Autonomic Neuropathies
1
Head and Neck Neoplasms
1
Endometrial Neoplasms
1
Breast Neoplasms, Male
1
Breast Diseases
1
Anovulation
1
Interventions
lutetium Lu 177 dotatate
4
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
olaparib
2
fludarabine
2
cabozantinib
2
X-Rays
2
Phantoms, Imaging
2
Cyclophosphamide
2
tivozanib
1
repotrectinib
1
pembrolizumab
1
pazopanib
1
fludarabine phosphate
1
entrectinib
1
belinostat
1
atezolizumab
1
aldesleukin
1
Yttrium-90
1
Temozolomide
1
Salts
1
Octreotide
1
Nivolumab
1
Introns
1
Interferon alpha-2
1
Immunoglobulin G
1
Etoposide
1
Disulfides
1
Cisplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroendocrine Tumors
×
Tamoxifen
×
30 days
×
Clear all
No trials found.